Applauds Health Canada’s Approval Of Psilocybin Compassionate Access For Patients NEW YORK, Aug. 6, 2020 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic
Vancouver, British Columbia–(Newsfile Corp. – August 6, 2020) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) majority owned subsidiary NeonMind Biosciences Inc. (“NeonMind”) announces
TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on
Toronto, Ontario–(Newsfile Corp. – August 5, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation
We are excited to share this incredibly important piece of news from TheraPsil, which represents the first legal medical exemption for psilocybin usage in Canada
DENVER, Aug. 04, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group™ (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) (“Mydecine”), is pleased to announce that its subsidiary, Mindleap Health™ (“Mindleap”
We spoke to Amadeus Diamond of The Entheos Foundation: New Zealand’s first charity supporting psychedelic research and education.
We spoke to Jack Hollingsworth DO., owner and operator of Pacific Psych Centers, about how he’s gearing up to offer psychedelic therapies…
We spoke to Cosmo Feilding Mellen, CEO of Beckley Psytech, about the new company’s plans…
We provide information, research, news and interviews from the emergent psychedelic sector in one place. Cut through the ‘shroom stock’ noise with Psilocybin Alpha.
Industry insights and interviews delivered to your inbox. No spam, just valuable information.
© Psilocybin Alpha 2020
